ESC Professional Premium Access

Covid-19 impact and management in patients with congenital heart disease and in patients with pulmonary hypertension

Event: ESC Congress 2022
Topic: Clinical
Session type: Moderated ePosters
Date: 29 August 2022
Time: 16:15 - 17:00

Congress Session

6 presentations in this session

Impact of coronavirus disease 2019 on adult patients with congenital heart disease

Speaker: Doctor I. Cardoso (Lisbon, PT)
Thumbnail

Adults with congenital heart disease and COVID-19

Speaker: Miss N. Langes (Munich, DE)
Thumbnail

COVID-19 infection and its impact on case-fatality in patients with pulmonary embolism

Speaker: Doctor L. Hobohm (Mainz, DE)
Thumbnail

Impact of COVID-19 pandemics upon nationwide pulmonary hypertension cohort: 18-months analysis of BNP-PL national database.

Speaker: Doctor A. Mamzer (Lodz, PL)
Thumbnail

Optimal thromboprophylaxis and anticoagulant strategies in patients with COVID-19 pneumonia. The PROTHROMCOVID Trial.

Speaker: Doctor N. Munoz-Rivas (Madrid, ES)
Thumbnail

COVID-19 vaccination in adults with congenital heart disease: results of 1-year prospective study

Speaker: Doctor A. Roma (Naples, IT)
Thumbnail

6 speakers from this session

Doctor Isabel Cardoso

Hospital de Santa Marta, Lisbon (Portugal)
3 presentations
0 follower

Miss Nora Langes

, Munich (Germany)
0 follower

Doctor Lukas Hobohm

University Medical Center of Mainz, Mainz (Germany)
3 presentations
0 follower

Doctor Aleksandra Mamzer

Bieganski Hospital, Medical University of Lodz, Lodz (Poland)
0 follower

Doctor Nuria Munoz-Rivas

Infanta Leonor Universitary Hospital, Madrid (Spain)
0 follower

Doctor Anna Selvaggia Roma

AORN Ospedali dei Colli - Monaldi Hospital, Naples (Italy)
0 follower

This platform is supported by

logo Novo Nordisk